Literature DB >> 27109463

CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs.

Ping Ji1, Yong Zhang1, Shu-Jun Wang1, Hai-Liang Ge1, Guo-Ping Zhao2, Ying-Chun Xu3, Ying Wang1.   

Abstract

It has been widely suggested that mammosphere-forming cells from tumor cell lines or primary tumors represent the population of cancer stem cells (CSCs), which is supposed to lead to the failure of routine chemotherapy and the recurrence of the disease. However, it is still difficult to obtain CSCs from primary breast cancer for further investigation. We performed a modified culture system to generate mammosphere-forming cells derived from freshly isolated human breast cancer samples and the breast cancer cell line MCF-7. Cancer stem cell-like phenotypes such as CD44 and CD24 were measured by flow cytometry while alkaline phosphatase (AP) and mammaglobin (MGB1) expression was evaluated immunohistochemically. The expression levels of Klf4, Nanog, Oct4, Sox2 and mdr1 genes were analyzed by quantitative real‑time PCR. Resistance to chemotherapeutic drugs was detected through the apoptosis assay upon drug treatments together with the detection of drug-resistant gene mdr1. The results revealed that we successfully obtained mammosphere‑forming cells from the primary breast cancer in conditioned medium after 14 days of culture. Mammosphere-forming cells from primary breast cancer displayed a CD44hiCD24lo phenotype as well as positive AP and MGB1 reactivity. Stem cell-related genes such as Klf4, Nanog and Oct4 were detectably expressed in these cells. These cells formed tumor-like structures in the lymph nodes of nude mice, which were morphologically and histologically similar to breast cancer. Compared to the breast cancer cell line MCF-7 or mammosphere-forming cells from MCF-7 cells, the mammosphere-forming cells from the primary breast cancer exhibited resistance to three of four first-line chemotherapeutic drugs investigated through the induction of apoptosis, which was largely associated with the increased expression of drug-resistant gene mdr1 upon drug treatment. In conclusion, mammosphere-forming cells generated from the primary breast cancer exhibit CSC-like properties together with multiple drug resistance. Determination of the sensitivity of these primary cancer-derived mammosphere-forming cells to chemotherapeutic drugs may thus provide useful instructions for individualized therapy against the recurrence of breast cancer in the future.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27109463     DOI: 10.3892/or.2016.4739

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  10 in total

1.  Ganoderma lucidum enhances carboplatin chemotherapy effect by inhibiting the DNA damage response pathway and stemness.

Authors:  Ivette J Suárez-Arroyo; Ariana Acevedo-Díaz; Tiffany J Ríos-Fuller; Gabriela Ortiz-Soto; Ricardo Vallejo-Calzada; Jael Reyes-Chea; Gerónimo Maldonado-Martínez; Robert J Schneider; Michelle M Martínez-Montemayor
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

2.  Single-Cell Tracking of Breast Cancer Cells Enables Prediction of Sphere Formation from Early Cell Divisions.

Authors:  Patrick C Bailey; Rachel M Lee; Michele I Vitolo; Stephen J P Pratt; Eleanor Ory; Kristi Chakrabarti; Cornell J Lee; Keyata N Thompson; Stuart S Martin
Journal:  iScience       Date:  2018-08-21

3.  Sensitivity of Papilloma Virus-Associated Cell Lines to Photodynamic Therapy with Curcumin-Loaded Liposomes.

Authors:  Ghazala Ambreen; Lili Duse; Imran Tariq; Uzma Ali; Sajid Ali; Shashank R Pinnapireddy; Michael Bette; Udo Bakowsky; Robert Mandic
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

4.  Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies.

Authors:  Adam Hermawan; Muthi Ikawati; Riris Istighfari Jenie; Annisa Khumaira; Herwandhani Putri; Ika Putri Nurhayati; Sonia Meta Angraini; Haruma Anggraini Muflikhasari
Journal:  Saudi Pharm J       Date:  2020-12-15       Impact factor: 4.330

5.  Tinzaparin inhibits VL30 retrotransposition induced by oxidative stress and/or VEGF in HC11 mouse progenitor mammary cells: Association between inhibition of cancer stem cell proliferation and mammosphere disaggregation.

Authors:  Stefania Mantziou; Georgios Markopoulos; Soteroula Thrasyvoulou; Dimitrios Noutsopoulos; Foteini Gkartziou; Georgios Vartholomatos; Theodore Tzavaras
Journal:  Oncol Rep       Date:  2021-09-24       Impact factor: 3.906

Review 6.  Liposomal curcumin and its application in cancer.

Authors:  Ting Feng; Yumeng Wei; Robert J Lee; Ling Zhao
Journal:  Int J Nanomedicine       Date:  2017-08-21

Review 7.  Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.

Authors:  Lia Walcher; Ann-Kathrin Kistenmacher; Huizhen Suo; Reni Kitte; Sarah Dluczek; Alexander Strauß; André-René Blaudszun; Tetyana Yevsa; Stephan Fricke; Uta Kossatz-Boehlert
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

8.  Curcumin Has Anti-Proliferative and Pro-Apoptotic Effects on Tongue Cancer in vitro: A Study with Bioinformatics Analysis and in vitro Experiments.

Authors:  Chao Ma; Zongming Zhuang; Qisheng Su; Jianfeng He; Haoyu Li
Journal:  Drug Des Devel Ther       Date:  2020-02-04       Impact factor: 4.162

9.  Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models.

Authors:  Maryam Nakhjavani; Eric Smith; Helen M Palethorpe; Yoko Tomita; Kenny Yeo; Tim J Price; Amanda R Townsend; Jennifer E Hardingham
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-30

10.  A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.

Authors:  Shubin Yu; Yiwen Lu; An Su; Jianing Chen; Jiang Li; Boxuan Zhou; Xinwei Liu; Qidong Xia; Yihong Li; Jiaqian Li; Min Huang; Yingying Ye; Qiyi Zhao; Sushi Jiang; Xiaoqing Yan; Xiaojuan Wang; Can Di; Jiayao Pan; Shicheng Su
Journal:  Adv Sci (Weinh)       Date:  2021-08-07       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.